SCHEMBL3164307

SCHEMBL3164307

NCCCCn1c(-c2ccccc2)cc2ccc(C(=O)c3cc(CC(=O)NO)c(-c4cccc(O)c4)s3)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.34
MTNR1B P49286 3/20 0.34
KMT2A Q03164 2/20 0.34
ACLY P53396 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NTRK1 P04629 3/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
HPGDS O60760 1/20 0.33
HSD17B1 P14061 3/20 0.32
HSD17B2 P37059 2/20 0.32
DYRK1A Q13627 1/20 0.32
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15117543 0.94 KMT2A (0.36) MTNR1AMTNR1BKMT2AACLYALDH1A1
SCHEMBL3175818 0.94 MTNR1A (0.34) MTNR1AMTNR1BKMT2AACLYALDH1A1
Hydrochloric Acid SCHEMBL3063391 0.94 MTNR1A (0.36) MTNR1AMTNR1BKMT2AACLYALDH1A1
SCHEMBL15117536 0.94 MTNR1A (0.36) MTNR1AMTNR1BKMT2AACLYALDH1A1
Hydrochloric Acid SCHEMBL3049509 0.93 MTNR1A (0.35) MTNR1AMTNR1BKMT2AACLYALDH1A1
Hydrochloric Acid SCHEMBL3049516 0.93 MTNR1A (0.35) MTNR1AMTNR1BKMT2AACLYALDH1A1
SCHEMBL2683553 0.91 MC4R (0.31) HPGDSPIK3R1PIK3CAHDAC1
SCHEMBL3174171 0.90 TP53 (0.36) MTNR1AMTNR1BKMT2AACLYALDH1A1
SCHEMBL3175258 0.90 NTRK1 (0.37) MTNR1AMTNR1BKMT2AACLYALDH1A1
SCHEMBL3173481 0.90 NTRK1 (0.39) MTNR1AMTNR1BKMT2AACLYALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US claimed
US-8492428-B2 Small-molecule botulinum toxin inhibitors MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-07-23 US disclosed
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100260778-A1 SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS BTD, RAC2, BTN3A1 MTNR1A 992/4885MTNR1B 759/4885KMT2A 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.